1 study on Erythropoietin receptor agonist mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**The findings suggest a potential preventative strategy for early-stage Alzheimer's, where ARA 290 could be used to modulate the immune system before significant pathology is established.** For biohackers or clinicia…